Pacira BioSciences Q4 2020 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Börse:
64,750€
0,39%
Echtzeit-Aktienkurs Pacira Pharmaceuticals Inc.
Bid:
63,500€
Ask:
66,000€
Nachrichten zur Pacira Pharmaceuticals Inc. Aktie
Pacira to Report 2020 Financial Results on Thursday February 25, 2021
PARSIPPANY, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report…
Pacira BioSciences reports January prelim net product sales
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021
EXPAREL average daily sales at 108% of the prior year for the month of January 2021 EXPAREL average daily sales…
Pacira BioSciences, Inc.: 8-K Report
8-K...…
Insiderhandel: President verkauft Aktien von Pacira Pharmaceuticals im Wert von 6.689 $
Reinhardt, Max - Vorstand - Tag der Transaktion: 2021-01-06...…
Pacira BioSciences reports subdued growth for 2020
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira BioSciences, Inc.: 8-K Report
8-K...…
Pacira Reports Record Revenue for 2020 of $429.6 Million
-- EXPAREL average daily sales at 109% of the prior year for the fourth quarter and 111% of the prior…
Pacira BioSciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
PARSIPPANY, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will…
Pacira BioSciences, Inc.: 8-K Report
8-K...…
Pacira BioSciences Reports Preliminary Net Product Sales of $38.9 Million for November 2020
-- EXPAREL average daily sales at 103% of the prior year for the month of November 2020 -- PARSIPPANY, N.J.,…
Pacira BioSciences to Present at the 2020 Piper Sandler 32nd Annual Virtual Healthcare Conference
PARSIPPANY, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will…
Pacira (PCRX) Gets European Commission Approval for Exparel
The EC approves Paciras (PCRX) Exparel for treating post-operative pain in adults and as a field block for treating somatic…
Pacira Receives European Commission Approval for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical Pain
--Approval based on four pivotal studies showing EXPAREL reduced pain scores and opioid use following surgery-- --EXPAREL is the first…
Pacira BioSciences Reports Preliminary Net Product Sales of $41.7 Million for October 2020
-- EXPAREL average daily sales at 112% of the prior year for the month of October 2020 -- -- EXPAREL…
Pacira BioSciences, Inc.: 10-Q Report
10-Q - PCRX - 9.30.2020...…
Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q3 2020 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira BioSciences, Inc. 2020 Q3 - Results - Earnings Call Presentation
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira (PCRX) Beats Q3 Earnings and Revenue Estimates
Pacira (PCRX) delivered earnings and revenue surprises of 3.03% and 1.90%, respectively, for the quarter ended September 2020. Do the…
Pacira BioSciences Q3 2020 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira Launches State-of-the-Art Training Center Dedicated to Advancing Best Practice Regional Approaches to Manage Acute Pain
--The Pacira Innovation and Training Center of Tampa will provide clinicians with a flexible environment for hands-on learning-- PARSIPPANY, N.J.,…
Pacira BioSciences (PCRX) Enters Oversold Territory
Pacira BioSciences (PCRX) has been on a bit of a cold streak lately, but there might be light at the…
Pacira to Report Third Quarter 2020 Financial Results on Thursday October 29, 2020
PARSIPPANY, N.J., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report…
Is Pacira BioSciences (PCRX) Outperforming Other Medical Stocks This Year?
Is (PCRX) Outperforming Other Medical Stocks This Year?...…
Insiderhandel: CEO and Chairman verkauft Aktien von Pacira Pharmaceuticals im Wert von 1.666.800 $
Stack, David M. - CEO and Chairman - Tag der Transaktion: 2020-10-16...…
Insiderhandel: CEO and Chairman verkauft Aktien von Pacira Pharmaceuticals im Wert von 1.665.900 $
Stack, David M. - CEO and Chairman - Tag der Transaktion: 2020-10-14...…
Insiderhandel: CEO and Chairman verkauft Aktien von Pacira Pharmaceuticals im Wert von 1.650.000 $
Stack, David M. - CEO and Chairman - Tag der Transaktion: 2020-10-15...…
Pacira Bio sees Exparel sales of $113.7M for Q3 2020
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira BioSciences Reports Preliminary Net Product Sales of $116.9 Million for the Third Quarter of 2020
-- EXPAREL average daily sales at 110% of the prior year for the third quarter and 110% of the prior…
Pacira BioSciences: Products And Management Can Maintain Outperformance Despite Q2 Sales Decline
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira (PCRX) Gains Positive CHMP Opinion for Exparel in EU
The CHMP gives a positive opinion recommending an approval for Paciras (PCRX) Exparel (bupivacaine liposome injectable suspension) to treat postsurgical…
Pacira Biosciences (PCRX) Investor Presentation - Slideshow
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira Receives Positive CHMP Opinion for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical Pain
-- CHMP opinion supported by four pivotal studies showing EXPAREL reduced pain scores and opioid use following surgery -- -- European…
IPG and Pacira BioSciences Announce Collaboration to Reduce Postsurgical Opioid Prescribing and Surgical Procedure Costs
ALPHARETTA, Ga. and PARSIPPANY, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- IPG, the industry-leading provider of surgical cost…
Pacira BioSciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference
PARSIPPANY, N.J., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will…
Is Pacira BioSciences (PCRX) Outperforming Other Medical Stocks This Year?
Is (PCRX) Outperforming Other Medical Stocks This Year?...…
Pacira BioSciences, Inc. (PCRX) Q2 2020 Earnings Call Transcript
PCRX earnings call for the period ending June 30, 2020....…
Pacira BioSciences, Inc.: 8-K/A Report
FORM 8-K...…
Pacira BioSciences, Inc.: 10-Q Report
10-Q...…
Pacira (PCRX) Misses Q2 Earnings and Revenue Estimates
Pacira (PCRX) delivered earnings and revenue surprises of -25.00% and -0.03%, respectively, for the quarter ended June 2020. Do the…
Pacira BioSciences Q2 2020 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients
sNDA submission based on positive Phase 3 data supporting expansion of the EXPAREL label to include use in children aged…
Pacira BioSciences Announces Settlement of Government Investigation
Pacira to Pay $3.5 Million to Settle Various Claims with No Admission of Wrongdoing Pacira to Pay $3.5 Million to…
3 Reasons Why Pacira (PCRX) Is a Great Growth Stock
Pacira (PCRX) possesses solid growth attributes, which could help it handily outperform the market....…
The Zacks Analyst Blog Highlights: Alpine Immune Sciences, Actinium Pharmaceuticals, Pacira BioSciences and Translate Bio
The Zacks Analyst Blog Highlights: Alpine Immune Sciences, Actinium Pharmaceuticals, Pacira BioSciences and Translate Bio...…
Pacira Bio prices $350M convertible debt offering
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pacira BioSciences, Inc. Announces Pricing of $350.0 Million Aggregate Principal Amount of 0.750% Convertible Senior Notes due 2025
PARSIPPANY, N.J., July 07, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced the pricing of…
Pacira (PCRX) Provides Preliminary Results for Second Quarter
Pacira (PCRX) reports preliminary results for the second quarter of 2020. The companys product sales are hurt by the COVID-19…
Pacira BioSciences under pressure on preliminary Q2 results
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…